Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
828,966
-
Share change
-
-55,000
-
Total reported value
-
$2,469,030
-
Price per share
-
$3.21
-
Number of holders
-
17
-
Value change
-
+$181,604
-
Number of buys
-
9
-
Number of sells
-
4
Institutional Holders of AKERS BIOSCIENCES INC - COM as of Q1 2021
As of 31 Mar 2021,
AKERS BIOSCIENCES INC - COM was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
828,966 shares.
The largest 10 holders included
Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Candriam Luxembourg S.C.A., NORTHERN TRUST CORP, We Are One Seven, LLC, CITADEL ADVISORS LLC, Private Advisor Group, LLC, and FNY Investment Advisers, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.